Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

ClinicalTrials.gov ID: NCT06700343

Public ClinicalTrials.gov record NCT06700343. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 11:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel-group Study to Compare Pharmacokinetics, Pharmacodynamics, Clinical Effects, and Safety Between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects With Relapsing-remitting Multiple Sclerosis

Study identification

NCT ID
NCT06700343
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
444 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 12, 2025
Primary completion
Jan 14, 2027
Completion
Dec 16, 2027
Last update posted
May 10, 2026

2025 – 2027

United States locations

U.S. sites
26
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
University of South Alabama Mobile Alabama 36617 Recruiting
Clinical Endpoints, LLC Scottsdale Arizona 85258 Recruiting
Profound Research - Neurology Center of Southern California Carlsbad California 92011 Recruiting
Mountain Neurological Research Center Basalt Colorado 81621 Recruiting
Advanced Neurosciences Research, Llc Fort Collins Colorado 80528 Recruiting
Hasbani Neurology New Haven Connecticut 06511 Recruiting
Neurology Offices of South Florida Boca Raton Florida 33428 Recruiting
Aqualane Clinical Research Naples Florida 34105 Recruiting
Emerald Coast Neurology/Synergy Clinical Research Pensacola Florida 32504 Recruiting
Knight Neurology Rockledge Florida 32955 Recruiting
Premiere Research Institute Palm Beach West Palm Beach Florida 33407 Recruiting
Hawaii Pacific Neuroscience Honolulu Hawaii 96817 Recruiting
University of Kansas Medical Center Kansas City Kansas 66160 Recruiting
Henry Ford Health Detroit Michigan 48202 Recruiting
Michigan Institute For Neurological Disorders (Glendale Neurological Associates) - Farmington Hills Farmington Michigan 48334-2979 Recruiting
JFK Medical Center Edison New Jersey 08820 Recruiting
Hackensack Meridian Health Paramus New Jersey 07652 Recruiting
University of NM/Mind Imaging center Albuquerque New Mexico 87131 Recruiting
Triad Neurological Associates Winston-Salem North Carolina 27103 Recruiting
Singlepoint Healthcare Opco, LLC Columbus Ohio 43235 Recruiting
NDx Clinical Research, Inc Dayton Ohio 45459 Recruiting
Premier Neurology, PC Greenville South Carolina 29650 Recruiting
Hope Neurology Knoxville Tennessee 37922 Recruiting
Vanderbilt University Medical Center (VUMC) Nashville Tennessee 37215 Recruiting
Lone Star Neurology Frisco Texas 75035 Recruiting
Froedtert Hospital-Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06700343, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06700343 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →